Ocular Therapeutix, Inc. revenue breakdown overview

Ocular Therapeutix, Inc. revenue for the last year amounted to 63.72 M USD, the most of which — 63.46 M USD — came from its highest performing source at the moment, Bioresorbable Hydrogel-based Formulation Technology, the year earlier bringing 57.87 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Ocular Therapeutix, Inc. 63.72 M USD, and the year before that — 58.44 M USD.